PharmaReview Corporation (PRC) represents a vibrant technology platform with a core management team lead by Dr. Marian Kruzel, founder and CEO. PRC Management Team – comprised of industry experts in Medical Science, Drug Development, Project Management, Business Development, Finance, and Entrepreneurship.
Dr. Kruzel is one of the world’s leading experts in the structure and function of lactoferrin. He has committed his career to discovering ways to effectively use and commercialize lactoferrin.
Dr. Kruzel is a faculty member at the Department of Integrative Biology and Pharmacology, UTHealth, McGovern Medical School at Houston. He authored and/or co-authored more than 100 peer-reviewed scientific papers and co-invented technologies covered by several patents. Also, he is a member of the editorial boards of: Archivum Immunologiae et Therapiae Experimentalis (current), Journal of Experimental Therapeutics and Oncology (current), International Journal of Hematology Research (current), and Journal of Alzheimer’s Disease (past).
In addition he is a member of NIH review panels on innovative immunology.